Navigation Links
Vermillion Announces Appointment of John Hamilton to Board of Directors
Date:4/10/2008

FREMONT, Calif., April 10 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced the appointment of John F. Hamilton to its board of directors. Mr. Hamilton is the former vice president and chief financial officer of Depomed, Inc., a specialty pharmaceutical company.

"John brings more than 20 years of active board-level engagement on financial, strategic and audit matters to Vermillion. His solid experience working with small to mid-size companies in the healthcare sector is a perfect fit with our business model," said Gail Page, President and CEO of Vermillion. "We are pleased to welcome John to the board, especially at such an exciting time in the company's evolution as we prepare to commercialize several of our diagnostic tests later this year. His financial savvy and analytical approach will prove invaluable to the Company."

Mr. Hamilton began his career in the banking industry and went on to hold senior financial positions at several biopharmaceutical companies including Glyko, Inc. -- now BioMarin Pharmaceuticals -- and Chiron Corporation. He sits on the regional board of directors of the Association of Bioscience Financial Officers and is past-president of the Treasurers Club of San Francisco. Mr. Hamilton received his M.B.A. from the University of Chicago and his B.A. in International Relations from the University of Pennsylvania.

Mr. Hamilton's appointment to Vermillion's board of directors went into effect on April 9, 2008. Additionally, Mr. Hamilton will serve as chairman of the Company's audit committee. He will replace Judy Bruner, executive vice president of administration and chief financial officer of SanDisk Corporation, who resigned from the board
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
2. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
3. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
4. Vermillion Announces Effectiveness of Reverse Stock Split
5. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
8. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
9. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
10. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
11. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mbassador to also Visit Detroit , ...vid Appia, French Ambassador for International Inv...nce Agency, , , , ,What: Ambassador Appia is avai...iness initiatives adopted by France to further dev...for innovation and development., , ,When: Availabl...
(Date:11/24/2009)...ewswire-FirstCall/--Sigma-AldrichCorporation(Nasda...nTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/C...overtheInternetavailableat http://inve s tor.si..."icontoaccessthisfile. ,, AboutSigma-Aldrich:...ogycompany.Itschemicalandbiochemicalproductsandkit...
(Date:11/24/2009)...ewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chinese...he,investigationalnewdrugapplication(IND)foritsora...ationtotreatdiabetes.ThisIND,approvalallowsBiolaxy...etesisadisordercharacteristicofhighbloodglucoseand...ultinseveremicro-and,macro-vasculardiseases,lossof...
(Date:11/24/2009)...RNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SH...oday,announcedthatithassubmittedaMAAtotheEuropeanM...zymereplacementtherapyindevelopment,forthetreatmen...licationforvelaglucerasealfathathasbeensubmitted,w... , Basedonaglobalsupplyshortageofthecurrently...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...nEarth Inc.,(OTC Bulletin Board: RNER; "the Compan...k Resources Inc. has been assigned a new symbol to... has become effective on May 21, 2009,according to... in conducting Hollow Fiber Mambrane,Materials, ap... Company has,launched a new English web site. The ...
...n provided jointly by leading international cardio... Investigators from the Phase III TRITON-TIMI 38 ...e Universal Definition of Myocardial Infarction to... with acute coronary syndromes (ACS) undergoing pe...prasugrel, as compared with patients taking clopid...
...AM, May 21 ,Agendia, a world leader in molecular c...searchers from Agendia, the University of Califor...itute will present data from multiple studies,at t...eting, May 29 - June 2,2009, in Orlando, Florida. ... predictive and prognostic,power of Agendia,s brea...
Other Biology Technology:RainEarth Inc. Changes Trading Symbol from GRKR to RNER 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 2Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting 3
(Date:11/23/2009)...by University of Alabama at Birmingham (UAB) resea...sting medical conditions (co-morbidity) do not exp...-Americans compared to Caucasians who also have co...in Cancer , a journal of the American Cancer Soci...nd co-morbidity are independent predictors of poor...
(Date:11/23/2009)...eveal in unprecedented detail how the ribosome int...ns and guide them toward their destination in biol...flexible fitting (MDFF) to examine the interaction...ners. , The first study, in Proceedings of the...ate signaling between the ribosome and an elongati...
(Date:11/23/2009)...t discoveries about the multiple health benefits o...pose nutrient, increased awareness of the huge num...search and even led to an appreciation of it as "n...e health of your immune system to prevention of he...itamin D is now seen as one of the most critical n...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Jeff Stewart Joins Decision Resources Inc as Chief Information Officer 50277 1Jeff Stewart Joins Decision Resources Inc as Chief Information Officer 50277 2BioStorage Technologies Inc Appoints Jeff Goddard to Global Head of Sales 12825 1BioStorage Technologies Inc Appoints Jeff Goddard to Global Head of Sales 12825 2Retirement Cruise Ship Nearing Launch 50276 1Retirement Cruise Ship Nearing Launch 50276 2
...,s Research Hospital have found key features that ...those that infect humans. , The St. Jude team us...mino acid building blocks that are statistically m...eins and those that are more likely to be in human...e amino acids can be used as markers to track chan...
...le with its front legs, how do its hind legs know ...f Current Biology, a publication of Cell Press, re...elf that leaves a lasting impression. By compariso... proved rather fleeting. , Indeed, the researche...ver a hurdle for at least ten minutes. The finding...
...rsity scientists have developed tiny, spherical na...drate-based drugs. The scientists created the nano...TRP), which will ultimately enable the nanogels to...ispense the drug in a time-release manner. , The ... many unique properties that make them ideal drug-...
Other Biology News:St. Jude influenza survey uncovers key differences between bird flu and human flu 2St. Jude influenza survey uncovers key differences between bird flu and human flu 3Tracking feline memories on the move 2Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs 2
...l Clamp One can operate as a Voltage Clamp, as a C...n electrophysiology research applications. Perform...alog equipment. • This amazing instrument...apabilities of Digital Signal Processing (DSP) int...
Dispensing Bins from Terra Universal, Inc.
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
Apparel Dispenser from Terra Universal, Inc.
Biology Products: